Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

This study has been completed.

Study NCT00398138 Information provided by National Cancer Institute (NCI)

First Received: November 9, 2006 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia
Lung Cancer
Malignant Mesothelioma
Myelodysplastic Syndromes
Peritoneal Cavity Cancer

Additional conditions recognized in this trial

Carcinoma, Non-Small-Cell Lung
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Lung Neoplasms
Mesothelioma
Peritoneal Neoplasms
Preleukemia
Syndrome

Interventions listed in this trial

WT-1 analog peptide vaccine
incomplete Freund's adjuvant
sargramostim
polymerase chain reaction
flow cytometry
immunoenzyme technique

Additional drug interventions recognized in this trial

Freund's Adjuvant

More general drug interventions related to this trial

Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs

Sponsors listed in this trial

Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content